CN101244239B - Chinese medicine for treating apoplexy hemiplegia sequela - Google Patents
Chinese medicine for treating apoplexy hemiplegia sequela Download PDFInfo
- Publication number
- CN101244239B CN101244239B CN2008100307688A CN200810030768A CN101244239B CN 101244239 B CN101244239 B CN 101244239B CN 2008100307688 A CN2008100307688 A CN 2008100307688A CN 200810030768 A CN200810030768 A CN 200810030768A CN 101244239 B CN101244239 B CN 101244239B
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- root
- ramulus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010019468 Hemiplegia Diseases 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title claims description 25
- 206010008190 Cerebrovascular accident Diseases 0.000 title description 6
- 208000006011 Stroke Diseases 0.000 title description 6
- 210000000582 semen Anatomy 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 11
- 241000903946 Clematidis Species 0.000 claims description 9
- 241000756943 Codonopsis Species 0.000 claims description 9
- 241001489978 Eupolyphaga Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241000237636 Pheretima Species 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 241000522620 Scorpio Species 0.000 claims description 9
- 239000009490 scorpio Substances 0.000 claims description 9
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 230000008506 pathogenesis Effects 0.000 abstract description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000601164 Clematis orientalis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 240000005779 Jasminum multiflorum Species 0.000 abstract 1
- 240000003271 Leonurus japonicus Species 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 235000005087 Malus prunifolia Nutrition 0.000 abstract 1
- 244000070406 Malus silvestris Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 241001369613 Stephania tetrandra Species 0.000 abstract 1
- 244000081822 Uncaria gambir Species 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 241000411851 herbal medicine Species 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 206010033799 Paralysis Diseases 0.000 description 12
- 210000003141 lower extremity Anatomy 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 9
- 210000001364 upper extremity Anatomy 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000006187 pill Substances 0.000 description 6
- 241000208340 Araliaceae Species 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 235000003140 Panax quinquefolius Nutrition 0.000 description 5
- 235000008434 ginseng Nutrition 0.000 description 5
- 206010013887 Dysarthria Diseases 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 4
- 229910052753 mercury Inorganic materials 0.000 description 4
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 208000026473 slurred speech Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000014604 Specific Language disease Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine in the treatment of sequels of stroke and hemiplegia. The active pharmaceutical ingredient and weight ratios are demonstrated as follows: ground beetle 3-10g, astragalus 9-40g, codonopsis pilosula extract 10-30g, leonurus japonicus 9-30g, danshen root 9-15g, cyathula root 5-10g, peach kernel 5-10g, Jiang Chong 10-20g, safflower 5-9g, rhizoma ligustici wallichii 5-15g, scorpion 3-9g, lumbricus 5-10g, red peony root 6-12g, poria cocos 5-15g, chinese starjasmine stem 6-12g, stephania root 5-15g, coix seed 9-30g, crab apple 9-12g, eucommia bark 6-15g, combined spicebush root 5-10g, largehead atractylodes rhizome 6-15g, oriental waterplantain rhizome 6-15g, milettia reticulata 10-20g, gambir plant 5-12g, angelica sinensis 5-15g, turmeric rhizome 5-9g, cassia twig 3-9g, mulberry twig 10-20g, chinese clematis root 6-10g. That the sequels of stroke and hemiplegia are difficult to cure is because that muscle and joints are blocked by phlegm and blood stasis, which is caused by the deficiency of Qi. The prescription based on the pathogenesis, by righting and supporting the healthy energy, activating blood circulation to dissipate blood stasis, reducing phlegm and adjusting the balance of Yin and Yang, removes the causes of the illness and the total efficiency for the prescription is more than 98%.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of the apoplectic hemiplegia sequela.
Background technology
The sickness rate of apoplexy, mortality rate and disability rate are all quite high, are the diseases of a class serious harm human health.This class disease incidence is hurried, with faint on ground suddenly, syncope, or facial hemiparalysis, dysphonia, hemiplegia etc. take place suddenly is feature.Its serious sequela is exactly the hemiplegia based on dyskinesia, and promptly hemiplegia does not also have a kind of real curable way at present clinically, is one of important subject of current medical circle so how to solve the apoplectic hemiplegia sequela.Though in China the report of some treatment apoplectic hemiplegia Chinese medicines is arranged also, taking effect of having is slow, it is not too obvious to improve symptom, and the price that has is more expensive, does not also have a kind of instant effect at present, and it is obvious to improve symptom, and low price can reach the Chinese medicine of curative effect.
Summary of the invention
The object of the present invention is to provide a kind of instant effect, it is obvious to improve symptom, and low price can reach the Chinese medicine of the treatment apoplectic hemiplegia sequela of curative effect.
Technical scheme of the present invention is: be made up of following crude drug and weight ratio thereof: Eupolyphaga Seu Steleophaga 3-10g, Radix Astragali 9-40g, Radix Codonopsis 10-30g, Herba Leonuri 9-30g, Radix Salviae Miltiorrhizae 9-15g, Radix Achyranthis Bidentatae 5-10g, Semen Persicae 5-10g, Rhizoma Zingiberis Recens worm 10-20g, Flos Carthami 5-9g, Rhizoma Chuanxiong 5-15g, Scorpio 3-9g, Pheretima 5-10g, Radix Paeoniae Rubra 6-12g, Poria 5-15g, Caulis Trachelospermi 6-12g, Radix Stephaniae Tetrandrae 5-15g, Semen Coicis 9-30g, Fructus Crataegi 9-12g, Cortex Eucommiae 6-15g, Radix Linderae 5-10g, Rhizoma Atractylodis Macrocephalae 6-15g, Rhizoma Alismatis 6-15g, Caulis Spatholobi 10-20g, Ramulus Uncariae Cum Uncis 5-12g, Radix Angelicae Sinensis 5-15g, Rhizoma Curcumae Longae 5-9g, Ramulus Cinnamomi 3-9g, Ramulus Mori 10-20g, Radix Clematidis 6-10g..
The preferred technical solution of the present invention is: be made up of following crude drug and weight ratio thereof: Eupolyphaga Seu Steleophaga 3-6g, Radix Astragali 6-15g, Radix Codonopsis 10-25g, Herba Leonuri 6-15g, Radix Salviae Miltiorrhizae 10-12g, Radix Achyranthis Bidentatae 6-8g, Semen Persicae 6-8g, Rhizoma Zingiberis Recens worm 12-18g, Flos Carthami 5-6g, Rhizoma Chuanxiong 6-10g, Scorpio 3-8g, Pheretima 5-8g, Radix Paeoniae Rubra 6-10g, Poria 6-10g, Caulis Trachelospermi 5-10g, Radix Stephaniae Tetrandrae 5-10g, Semen Coicis 10-20g, Fructus Crataegi 10-12g, Cortex Eucommiae 7-10g, Radix Linderae 5-9g, Rhizoma Atractylodis Macrocephalae 6-12g, Rhizoma Alismatis 7-12g, Caulis Spatholobi 10-15g, Ramulus Uncariae Cum Uncis 6-10g, Radix Angelicae Sinensis 8-10g, Rhizoma Curcumae Longae 6-8g, Ramulus Cinnamomi 5-7g, Ramulus Mori 10-15g, Radix Clematidis 6-8g.
Best-of-breed technology scheme of the present invention is: be made up of following crude drug and weight ratio thereof: Eupolyphaga Seu Steleophaga 9g, Radix Astragali 30g, Radix Codonopsis 30g, Herba Leonuri 15g, Radix Salviae Miltiorrhizae 15g, Radix Achyranthis Bidentatae 10g, Semen Persicae 10g, Rhizoma Zingiberis Recens worm 9g, Flos Carthami 9g, Rhizoma Chuanxiong 10g, Scorpio 9g, Pheretima 10g, Radix Paeoniae Rubra 12g, Poria 10g, Caulis Trachelospermi 10g, Radix Stephaniae Tetrandrae 10g, Semen Coicis 15g, Fructus Crataegi 10g, Cortex Eucommiae 15g, Radix Linderae 10g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Alismatis 10g, Caulis Spatholobi 20g, Ramulus Uncariae Cum Uncis 9g, Radix Angelicae Sinensis 15g, Rhizoma Curcumae Longae 9g, Ramulus Cinnamomi 5g, Ramulus Mori 20g, Radix Clematidis 10g.
Prescription of the present invention is to be that healthy energy is deficient, the phlegm-turbidity and blood stasis stasis is stayed between the muscles and bones joint from the reason that apoplectic hemiplegia sequela refractory is healed, the pathogenesis that blocks meridians sets out, by strengthening the body resistance, benefiting QI for activating blood circulation blood stasis dispelling, channels sootheing and network vessel quickening eliminates the phlegm, the regulating YIN and YANG balance, thereby eliminate the factor of curing the disease, fundamentally realize curing.
Chinese medicine of the present invention can be made various preparations according to conventional pharmaceutical methods: as pill (honeyed pill or the watered pill), tablet, electuary, capsule, oral liquid etc.
The present invention has 6 big characteristics: (1) changes pertinacious phlegm, blood stasis dispelling blood is not hindered fresh blood, and is respond well, and effect is lasting.(2) benefiting QI for activating blood circulation, foster beniol warp, relaxing muscles and tendons and activating QI and blood in the collateral, effect uniqueness.(3) repair the cerebrovascular wound, impaired function of nervous system is recovered early.(4), imitate contrast with similar medication, effect rapidly, instant effect, it is obvious to improve symptom.(5) simple for production, low price has no side effect, and cure rate height, total effective rate are more than 98%, and (6) medicine source is wide, and market is big, and very big DEVELOPMENT PROSPECT is arranged.
The specific embodiment
Embodiment 1: paralysis is the health pill more: be made up of following crude drug and weight ratio thereof:
Eupolyphaga Seu Steleophaga 9g, Radix Astragali 30g, Radix Codonopsis 30g, Herba Leonuri 15g, Radix Salviae Miltiorrhizae 15g, Radix Achyranthis Bidentatae 10g, Semen Persicae 10g, Rhizoma Zingiberis Recens worm 9g, Flos Carthami 9g, Rhizoma Chuanxiong 10g, Scorpio 9g, Pheretima 10g, Radix Paeoniae Rubra 12g, Poria 10g, Caulis Trachelospermi 10g, Radix Stephaniae Tetrandrae 10g, Semen Coicis 15g, Fructus Crataegi 10g, Cortex Eucommiae 15g, Radix Linderae 10g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Alismatis 10g, Caulis Spatholobi 20g, Ramulus Uncariae Cum Uncis 9g, Radix Angelicae Sinensis 15g, Rhizoma Curcumae Longae 9g, Ramulus Cinnamomi 5g, Ramulus Mori 20g, Radix Clematidis 10g.
Method for making: above all medicines are pressed the property process of preparing Chinese medicine, dry porphyrize powder, and making pellets by mixing medical powder with honey or water are general to be pill.The heavy 9g of every ball.
Function: benefiting QI for activating blood circulation blood stasis dispelling, the channels sootheing and network vessel quickening that eliminates the phlegm, regulating YIN and YANG balance.
Cure mainly: apoplexy sequela, disease is seen hemiplegia, numb limbs and tense tendons, brothers' swelling, facial hemiparalysis, dysphasia, slobbering, shortness of breath and fatigue, hemiplegia or panplegia, the twin pain of muscle arteries and veins, lumbago and skelalgia, dizziness headache etc.
Usage: every day 2 times, each 1 ball, eliminating cold for resuscitation water or yellow wine take, and 26 days was 1 course of treatment.
Taboo: avoid pungent, greasy, anemia of pregnant woman forbidding, diabetes sequela patient obeys paralysis, and more health watered pill instructions about how to take medicine are the same.
The proved recipe clinical observation experiment sees the following form:
Table 1 is a total effects observation experiment table:
Table one
| Group | The example number | Produce effects | Effectively | Invalid | Total effective rate |
| The proved recipe paralysis is health more | 100 | 78 | 20 | 2 | 98％ |
| The ginseng restorative bolus | 100 | 25 | 48 | 27 | 73％ |
Table 2 is a disease observation of curative effect table
Table two
| Name of disease | Group | The example number | Produce effects | Effectively | Invalid | Total effective rate |
| Apoplexy sequela | Paralysis is health more | 30 | 20 | 9 | 1 | 98％ |
| The ginseng restorative bolus | 20 | 4 | 10 | 6 | 70％ | |
| Cerebral infarction sequela | Paralysis is health more | 30 | 19 | 9 | 2 | 97％ |
| The ginseng restorative bolus | 20 | 5 | 8 | 7 | 65％ | |
| Cerebral infarction sequela | Paralysis is health more | 30 | 22 | 8 | 0 | 100％ |
| The ginseng restorative bolus | 20 | 4 | 10 | 6 | 70％ | |
| The traumatic paralysis sequela | Paralysis is health more | 30 | 10 | 8 | 2 | 90％ |
| The ginseng restorative bolus | 20 | 1 | 3 | 6 | 40％ |
Table 3 is that table is observed in liver, renal function influence
Table three
| Project | Group | Number | Before the treatment | After the treatment | ||
| Liver function | Paralysis is health more | 60 | Positive constant | Unusually several | Positive constant | Unusually several |
| 59 | 1 | 59 | 1 | |||
| Renal function | Paralysis is health more | 60 | 60 | 0 | 60 | 0 |
Table 4 is observed table for toxicity, side effect:
Table four
| The animal medicine feed is observed | ||||||
| Medicine feed 3 months | The outward appearance behavior | Diet | Stool | Urine | Body weight | Blood testing |
| Before the administration | Normally | Normally | Normally | Normally | Normally | Normally |
| After the administration | Normally | Normally | Normally | Normally | Normally | Normally |
Model case:
Case 1: to so-and-so, the woman, 70 years old, the peasant, Ge Zhu level ground, Xupu County Quelling Star bridge people from village is in malfunctioning, in a certain state of delirium, the slurred speech of the right upper and lower extremities, slobbering suddenly at noon on August 29th, 1998.Examine through certain hospital and to be the cerebral infarction apoplexy, in hospitalize February have a surplus, the state of an illness takes a turn for the better to some extent and leaves hospital, stay sequela, the right upper and lower extremities hemiplegia, family members come to give to adopt proved recipe (paralysis is health more) treatment 20 days, patient just can slowly walk, continue and obeyed proved recipe one month, the patient gets well, and is still alive so far.
Case 2: Zan so-and-so, the woman, 69 years old, the peasant, Xupu County dragon's pool town rock beam people from village, morning April 26 calendar year 2001 unexpected Hemorrhagic strokes, hospital treated 8 months for him, still was unable to leave the bed.Xiang Zuowei doctor initiatively to the doorstep for old lady with more health treatment of paralysis, through the treatment after 10 days.Various symptoms take a favorable turn, the patient can own cane walking 30 surplus the step.Recurrence is not seen with anti-1 year in continue clothes top 50 days and fully recovering, and is still alive so far.
Case 3: Zhang, man, peasant, 58 years old, people from village of distant and out of sight Zhushan County, town, Ge Zhu level ground, Xupu County, afternoon on March 16th, 2003, work in the field, prominent sense is dizzy, left side upper and lower extremities inconvenient activity, after people's support is gone home, various sxs, slurred speech, slobbering, left side upper and lower extremities is malfunctioning, gatism.Surplus in the local hospital treatment moon, the commentaries on classics of not getting better of various symptoms because of the household economy difficulty, is left hospital and is gone home please several doctors to cure to have a surplus February not see doing well,improving.Its family members come to give diagnosis and treatment, examine its left hand deep-thready pulse, right hand thready and stringy pulse, and blood pressure 170/101 millimetres of mercury, language still can cooperate, and is unable to leave the bed, and left side upper and lower extremities stays the hemiplegia sequela.Took proved recipe 18 days, various symptoms obviously alleviate, can walk 20 under helping surplus the step.The clothes proved recipe that continues was nursed one's health and was healed in 20 days, did not see recurrence so far, can descend the field work.
Case 4: Wu so-and-so, man, 52 years old, the peasant, transverse slat bridge township, Xupu County Yan Wan people from village, before 5 months one day, work in the fields when going home to have lunch, prominent sense left side upper and lower extremities is malfunctioning, inarticulateness, send the local hospitalize moon surplus, the commentaries on classics of not getting better of various symptoms comes to give treatment upon somebody's introduction, examine lower limb hemiplegia under its left side, be easy to cry and laugh at, language still can cooperate, blood pressure 165/98 millimetres of mercury.Take proved recipe, treat February, its sick recovery from illness, healthy so far, do not see recurrence, often descend the field to work always.
Case 5: Tang so-and-so, man 66 years old, Xupu County dragon's pool town dragon's fountain village village branch secretary.Noon on May 7th, 2002, prominent sense left side upper and lower extremities inconvenience please be given diagnosis and treatment, fully recovered through therapy of combining Chinese and Western medicine, in morning July 15 this year, prominent sense left side upper and lower extremities is malfunctioning, inarticulateness, in various sxs at noon, patient's severe coma, blood pressure 201/120 millimetres of mercury, the left hand wiry and frequent pulse, right hand stringy and rolling pulse, gatism, the state of an illness is quite critical, the employing Chinese and western medicine is rescued, and through the symptomatic treatment of 1 wheat harvesting period, various symptoms are clearly better, language can cooperate, blood pressure 152/96 millimetres of mercury, diet is normal, and defecation is normal, stay left side upper and lower extremities hemiplegia sequela, adopt proved recipe to treat 1 month and rehabilitation, do not see the apoplexy recurrence so far, healthy.
Eupolyphaga Seu Steleophaga 5g, Radix Astragali 15g, Radix Codonopsis 30g, Herba Leonuri 15g, Radix Salviae Miltiorrhizae 15g, Radix Achyranthis Bidentatae 5g, Semen Persicae 9g, Rhizoma Zingiberis Recens worm 10g, Flos Carthami 6g, Rhizoma Chuanxiong 10g, Scorpio 5g, Pheretima 9g, Radix Paeoniae Rubra 12g, Poria 10g, Caulis Trachelospermi 10g, Radix Stephaniae Tetrandrae 10g, Semen Coicis 9g, Fructus Crataegi 9g, Cortex Eucommiae 10g, Radix Linderae 5g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Alismatis 10g, Caulis Spatholobi 10g, Ramulus Uncariae Cum Uncis 5g, Radix Angelicae Sinensis 10g, Rhizoma Curcumae Longae 5g, Ramulus Cinnamomi 3g, Ramulus Mori 10g, Radix Clematidis 9g.
Embodiment 2: as different from Example 1: be made up of following crude drug and weight ratio thereof:
Eupolyphaga Seu Steleophaga 6g, Radix Astragali 20g, Radix Codonopsis 15g, Herba Leonuri 10g, Radix Salviae Miltiorrhizae 10g, Radix Achyranthis Bidentatae 9g, Semen Persicae 6g, Rhizoma Zingiberis Recens worm 12g, Flos Carthami 5g, Rhizoma Chuanxiong 12g, Scorpio 5g, Pheretima 8g, Radix Paeoniae Rubra 9g, Poria 15g, Caulis Trachelospermi 9g, Radix Stephaniae Tetrandrae 10g, Semen Coicis 15g, Fructus Crataegi 10g, Cortex Eucommiae 10g, Radix Linderae 10g, Rhizoma Atractylodis Macrocephalae 15g, Rhizoma Alismatis 10g, Caulis Spatholobi 15g, Ramulus Uncariae Cum Uncis 10g, Radix Angelicae Sinensis 15g, Rhizoma Curcumae Longae 9g, Ramulus Cinnamomi 5g, Ramulus Mori 10g, Radix Clematidis 10g.
Embodiment 3: as different from Example 1: be made up of following crude drug and weight ratio thereof:
Eupolyphaga Seu Steleophaga 8g, Radix Astragali 30g, Radix Codonopsis 30g, Herba Leonuri 20g, Radix Salviae Miltiorrhizae 15g, Radix Achyranthis Bidentatae 6g, Semen Persicae 9g, Rhizoma Zingiberis Recens worm 9g, Flos Carthami 6g, Rhizoma Chuanxiong 10g, Scorpio 6g, Pheretima 10g, Radix Paeoniae Rubra 15g, Poria 12g, Caulis Trachelospermi 12g, Radix Stephaniae Tetrandrae 10g, Semen Coicis 12g, Fructus Crataegi 12g, Cortex Eucommiae 15g, Radix Linderae 12g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Alismatis 12g, Caulis Spatholobi 12g, Ramulus Uncariae Cum Uncis 9g, Radix Angelicae Sinensis 20g, Rhizoma Curcumae Longae 9g, Ramulus Cinnamomi 5g, Ramulus Mori 10g, Radix Clematidis 10g..
Claims (2)
1. a Chinese medicine for the treatment of the apoplectic hemiplegia sequela is characterized in that: be made up of following crude drug and weight ratio thereof: Eupolyphaga Seu Steleophaga 3-10g, Radix Astragali 9-40g, Radix Codonopsis 10-30g, Herba Leonuri 9-30g, Radix Salviae Miltiorrhizae 9-15g, Radix Achyranthis Bidentatae 5-10g, Semen Persicae 5-10g, Rhizoma Zingiberis Recens worm 10-20g, Flos Carthami 5-9g, Rhizoma Chuanxiong 5-15g, Scorpio 3-9g, Pheretima 5-10g, Radix Paeoniae Rubra 6-12g, Poria 5-15g, Caulis Trachelospermi 6-12g, Radix Stephaniae Tetrandrae 5-15g, Semen Coicis 9-30g, Fructus Crataegi 9-12g, Cortex Eucommiae 6-15g, Radix Linderae 5-10g, Rhizoma Atractylodis Macrocephalae 6-15g, Rhizoma Alismatis 6-15g, Caulis Spatholobi 10-20g, Ramulus Uncariae Cum Uncis 5-12g, Radix Angelicae Sinensis 5-15g, Rhizoma Curcumae Longae 5-9g, Ramulus Cinnamomi 3-9g, Ramulus Mori 10-20g, Radix Clematidis 6-10g..
2. a Chinese medicine for the treatment of the apoplectic hemiplegia sequela is characterized in that: be made up of following crude drug and weight ratio thereof: Eupolyphaga Seu Steleophaga 9g, Radix Astragali 30g, Radix Codonopsis 30g, Herba Leonuri 15g, Radix Salviae Miltiorrhizae 15g, Radix Achyranthis Bidentatae 10g, Semen Persicae 10g, Rhizoma Zingiberis Recens worm 9g, Flos Carthami 9g, Rhizoma Chuanxiong 10g, Scorpio 9g, Pheretima 10g, Radix Paeoniae Rubra 12g, Poria 10g, Caulis Trachelospermi 10g, Radix Stephaniae Tetrandrae 10g, Semen Coicis 15g, Fructus Crataegi 10g, Cortex Eucommiae 15g, Radix Linderae 10g, Rhizoma Atractylodis Macrocephalae 10g, Rhizoma Alismatis 10g, Caulis Spatholobi 20g, Ramulus Uncariae Cum Uncis 9g, Radix Angelicae Sinensis 15g, Rhizoma Curcumae Longae 9g, Ramulus Cinnamomi 5g, Ramulus Mori 20g, Radix Clematidis 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100307688A CN101244239B (en) | 2008-03-07 | 2008-03-07 | Chinese medicine for treating apoplexy hemiplegia sequela |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100307688A CN101244239B (en) | 2008-03-07 | 2008-03-07 | Chinese medicine for treating apoplexy hemiplegia sequela |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101244239A CN101244239A (en) | 2008-08-20 |
| CN101244239B true CN101244239B (en) | 2010-12-08 |
Family
ID=39945061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100307688A Expired - Fee Related CN101244239B (en) | 2008-03-07 | 2008-03-07 | Chinese medicine for treating apoplexy hemiplegia sequela |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101244239B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101450126B (en) * | 2009-01-09 | 2010-12-29 | 黑颖睿 | Formula for treating lower-limb deep veins thrombus |
| SI2411028T1 (en) * | 2009-03-27 | 2019-09-30 | Moleac Pte Ltd | Therapy for promoting cell growth |
| CN103961650A (en) * | 2014-05-15 | 2014-08-06 | 夏凯 | Medicine for treating limb movement disturbance caused by cerebrovascular diseases |
| CN104056080A (en) * | 2014-07-07 | 2014-09-24 | 张秀和 | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae |
| CN105878769A (en) * | 2014-10-08 | 2016-08-24 | 马中杰 | Medicine formula for preventing cerebral infarction and treating stroke sequelae |
| CN105125788A (en) * | 2015-08-06 | 2015-12-09 | 马少川 | Nerve injury recovery powder |
| CN105998805A (en) * | 2016-06-27 | 2016-10-12 | 陈中元 | Medicine for treating left hemiplegia of male and preparation method thereof |
| CN110251570A (en) * | 2019-06-20 | 2019-09-20 | 珠海横琴新区德群中医药科学研究院有限公司 | It is a kind of for treating the Chinese medicine composition of hemiplegia |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081888A (en) * | 1993-01-01 | 1994-02-16 | 河南省中药研究所 | Treatment commonly encountered diseases of internal department, the apoplexy of frequently-occurring disease and the Chinese patent medicine tablet of sequela |
| CN1190014A (en) * | 1998-02-17 | 1998-08-12 | 刘煌清 | Medicine for hemiplegia |
| CN1362200A (en) * | 2001-01-02 | 2002-08-07 | 杨孟君 | Nano apoplexy-treating Zhongfenghuichun medicine and its preparation |
-
2008
- 2008-03-07 CN CN2008100307688A patent/CN101244239B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081888A (en) * | 1993-01-01 | 1994-02-16 | 河南省中药研究所 | Treatment commonly encountered diseases of internal department, the apoplexy of frequently-occurring disease and the Chinese patent medicine tablet of sequela |
| CN1190014A (en) * | 1998-02-17 | 1998-08-12 | 刘煌清 | Medicine for hemiplegia |
| CN1362200A (en) * | 2001-01-02 | 2002-08-07 | 杨孟君 | Nano apoplexy-treating Zhongfenghuichun medicine and its preparation |
Non-Patent Citations (8)
| Title |
|---|
| 单凤琴.益气活络逐瘀汤治疗中风偏瘫后遗症56例临床观察.湖南中医药大学学报27 3.2007,27(3),51-53. |
| 单凤琴.益气活络逐瘀汤治疗中风偏瘫后遗症56例临床观察.湖南中医药大学学报27 3.2007,27(3),51-53. * |
| 张怀宇等.中医分型治疗中风偏瘫后遗症.西北国防医学杂志17 3.1996,17(3),214-215. |
| 张怀宇等.中医分型治疗中风偏瘫后遗症.西北国防医学杂志17 3.1996,17(3),214-215. * |
| 王树强.知麻汤治疗中风偏瘫后遗症37例.河南中医26 12.2006,26(12),37-38. |
| 王树强.知麻汤治疗中风偏瘫后遗症37例.河南中医26 12.2006,26(12),37-38. * |
| 陈敏等.补脾治瘫汤治疗中风偏瘫后遗症42例.中国民间疗法12 6.2004,12(6),48-49. |
| 陈敏等.补脾治瘫汤治疗中风偏瘫后遗症42例.中国民间疗法12 6.2004,12(6),48-49. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101244239A (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101244239B (en) | Chinese medicine for treating apoplexy hemiplegia sequela | |
| CN100506266C (en) | Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae | |
| CN102038758B (en) | rheumatism preparation for treating rheumatism | |
| CN100473411C (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
| CN101879291A (en) | Depression relieving and tranquilizing mixed decoction (powder) and pills | |
| CN102366556A (en) | Medicine for treating cerebral embolism sequela and preparation method thereof | |
| CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
| CN103110874A (en) | Kidney and spleen tonifying pill for human body regulation therapy | |
| CN100441212C (en) | Chinese medicine for treating cardiac failure | |
| CN102526592B (en) | Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases and immune dysfunction | |
| CN104258366A (en) | Traditional Chinese medicine preparation for lumbago and preparation method thereof | |
| CN102526635A (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN101919924A (en) | A kind of pharmaceutical composition for treating depression and its preparation method and application | |
| CN104435551A (en) | Traditional Chinese medicine composition for treating hemiplegia | |
| CN105250549A (en) | Traditional Chinese medicine composition for relieving sequela of apoplexy | |
| CN103536815A (en) | Traditional Chinese medicinal composition for treating hemorrhoids symptoms | |
| CN103405733A (en) | Chinese medicine preparation for treating joint pain of middle aged and elderly people | |
| CN101829306B (en) | A Chinese medicinal composition for treating hemiplegia, and its preparation method | |
| CN103495108A (en) | Medicine for treating chronic hypotension and preparation method for medicine | |
| CN103751418A (en) | Traditional Chinese medicine composition for treating restless leg syndrome | |
| CN103157006A (en) | Oral traditional Chinese medicine formula for treating osteoarthritis | |
| CN102512543A (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN101862430B (en) | Chinese medicament for treating femoral head necrosis and preparation method thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101623460B (en) | Medicine for treating rheumatic pain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101208 Termination date: 20160307 |